This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (311)

Published on in Vol 6, No 8 (2017): August

Ivermectin Treatment in Patients With Onchocerciasis-Associated Epilepsy: Protocol of a Randomized Clinical Trial

Ivermectin Treatment in Patients With Onchocerciasis-Associated Epilepsy: Protocol of a Randomized Clinical Trial

Ivermectin Treatment in Patients With Onchocerciasis-Associated Epilepsy: Protocol of a Randomized Clinical Trial

Authors of this article:

Robert Colebunders1 Author Orcid Image ;   Michel Mandro2 Author Orcid Image ;   Deby Mukendi3 Author Orcid Image ;   Housseini Dolo1 Author Orcid Image ;   Patrick Suykerbuyk1 Author Orcid Image ;   Marieke Van Oijen1 Author Orcid Image
Article Authors Cited by (18) Tweetations (4) Metrics

Journals

  1. Johnson T, Sejvar J, Nutman T, Nath A. The Pathogenesis of Nodding Syndrome. Annual Review of Pathology: Mechanisms of Disease 2020;15(1):395 View
  2. Siewe Fodjo J, Dekker M, Idro R, Mandro M, Preux P, Njamnshi A, Colebunders R. Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys. Infectious Diseases of Poverty 2019;8(1) View
  3. Stacey H, Woodhouse L, Welburn S, Jones J. Aetiologies and therapies of nodding syndrome: a systematic review and meta-analysis. Journal of Global Health Reports 2019;3 View
  4. Vinkeles Melchers N, Mollenkopf S, Colebunders R, Edlinger M, Coffeng L, Irani J, Zola T, Siewe J, de Vlas S, Winkler A, Stolk W. Burden of onchocerciasis-associated epilepsy: first estimates and research priorities. Infectious Diseases of Poverty 2018;7(1) View
  5. Siewe Fodjo J, Mandro M, Mukendi D, Tepage F, Menon S, Nakato S, Nyisi F, Abhafule G, Wonya’rossi D, Anyolito A, Lokonda R, Hotterbeekx A, Colebunders R, Wanji S. Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density. PLOS Neglected Tropical Diseases 2019;13(7):e0007300 View
  6. Hotterbeekx A, Perneel J, Mandro M, Abhafule G, Siewe Fodjo J, Dusabimana A, Abrams S, Kumar-Singh S, Colebunders R. Comparison of Diagnostic Tests for Onchocerca volvulus in the Democratic Republic of Congo. Pathogens 2020;9(6):435 View
  7. Mandro M, Siewe Fodjo J, Mukendi D, Dusabimana A, Menon S, Haesendonckx S, Lokonda R, Nakato S, Nyisi F, Abhafule G, Wonya’Rossi D, Jakwong J, Suykerbuyk P, Meganck J, Hotterbeekx A, Colebunders R, Goletti D. Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial. PLOS Neglected Tropical Diseases 2020;14(1):e0007966 View
  8. Colebunders R, Mandro M, Njamnshi A, Boussinesq M, Hotterbeekx A, Kamgno J, O’Neill S, Hopkins A, Suykerbuyk P, Basáñez M, Post R, Pedrique B, Preux P, Stolk W, Nutman T, Idro R. Report of the first international workshop on onchocerciasis-associated epilepsy. Infectious Diseases of Poverty 2018;7(1) View
  9. Hotterbeekx A, Dusabimana A, Mandro M, Abhafule G, Deogratias W, Siewe Fodjo J, Abrams S, Colebunders R. Urinary N-acetyltyramine-O,β-glucuronide in Persons with Onchocerciasis-Associated Epilepsy. Pathogens 2020;9(3):191 View
  10. Colebunders R, Nelson Siewe F, Hotterbeekx A. Onchocerciasis-Associated Epilepsy, an Additional Reason for Strengthening Onchocerciasis Elimination Programs. Trends in Parasitology 2018;34(3):208 View
  11. Walker M, Hamley J, Milton P, Monnot F, Pedrique B, Basáñez M. Designing antifilarial drug trials using clinical trial simulators. Nature Communications 2020;11(1) View
  12. Velghe S, Delahaye L, Ogwang R, Hotterbeekx A, Colebunders R, Mandro M, Idro R, Stove C. Dried Blood Microsampling-Based Therapeutic Drug Monitoring of Antiepileptic Drugs in Children With Nodding Syndrome and Epilepsy in Uganda and the Democratic Republic of the Congo. Therapeutic Drug Monitoring 2020;42(3):481 View
  13. Siewe Fodjo J, Mandro M, Wonya'rossi D, Inaç Y, Ngave F, Lokonda R, Anyolito A, Verelst F, Colebunders R. Economic Burden of Epilepsy in Rural Ituri, Democratic Republic of Congo. EClinicalMedicine 2019;9:60 View
  14. Colebunders R, Njamnshi A, Menon S, Newton C, Hotterbeekx A, Preux P, Hopkins A, Vaillant M, Siewe Fodjo J, Bennuru S. Onchocerca volvulus and epilepsy: A comprehensive review using the Bradford Hill criteria for causation. PLOS Neglected Tropical Diseases 2021;15(1):e0008965 View
  15. Dusabimana A, Tsebeni Wafula S, Raimon S, Fodjo J, Bhwana D, Tepage F, Abd-Elfarag G, Hotterbeekx A, Abrams S, Colebunders R. Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with Onchocerca volvulus. Pathogens 2020;10(1):21 View
  16. Angwafor S, Bell G, Ngarka L, Otte W, Tabah E, Nfor L, Njamnshi T, Njamnshi A, Sander J. Incidence and prevalence of epilepsy and associated factors in a health district in North-West Cameroon: A population survey. Epilepsy & Behavior 2021;121:108048 View
  17. Manavi M, Mohammad Jafari R, Shafaroodi H, Ejtemaei-Mehr S, Sharifzadeh M, Dehpour A. Anticonvulsant effects of ivermectin on pentylenetetrazole- and maximal electroshock-induced seizures in mice: the role of GABAergic system and KATP channels. Heliyon 2022;8(11):e11375 View
  18. Goel D, Srivastava A, Aledo-Serrano Á, Krishnan A, Vohora D. Pharmacotherapy for SARS-CoV-2 and Seizures for Drug Repurposing Presumed on Mechanistic Targets. Current Molecular Pharmacology 2022;15(6):832 View